Veradermics VDPHL01 Topline Results for Extended-Release Oral Minoxidil Minoxidil 4/27/2026
Veradermics is working on FDA approval for extended-release oral Minoxidil. Approval is expected around 2027.
View this post in the Community →
Similar Community Posts Join
5 / 1000+ resultscommunity Want to come off minoxidil properly - will this work?
Stopping minoxidil will likely result in losing any gains made from its use, potentially returning hair to its pre-treatment state or worse due to ongoing hair loss. The user plans to continue using finasteride and undergo a hair transplant, hoping it will compensate for any loss from stopping minoxidil.
community Veradermics VDPHL01 Topline Results for Extended-Release Oral Minoxidil
Extended-release oral minoxidil (VDPHL01) shows promising results for hair growth with improved safety, achieving significant hair count increases and minimal side effects compared to placebo. The treatment is designed to maintain effective concentrations while reducing side effects, making it a safer option for those who cannot tolerate standard minoxidil.
community Your experiences with minoxidil?
Minoxidil is effective for many users, with some experiencing initial shedding before seeing regrowth, while others report side effects like facial edema and heart pain. Combining minoxidil with finasteride or other treatments can enhance results, but individual experiences vary widely.
community Moving to 5mg Oral Minoxidil? Is it safe?
The conversation discusses increasing the dose of oral minoxidil from 2.5mg to 5mg for better hair density, with concerns about potential side effects like heart rate changes and fluid retention. Users suggest consulting a doctor, considering individual tolerance, and exploring other treatments like dutasteride.
community Taking a break off oral minoxidil after 2 years of everyday use.
The conversation is about a user taking a break from oral minoxidil due to persistent eye puffiness after two years of use. Suggestions include switching to topical minoxidil foam and adjusting the dosage to manage side effects.
Related Research
6 / 1000+ results
research Minoxidil: mechanisms of action on hair growth
Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.
research A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
5% minoxidil works better for hair growth and density, with minor irritation.
research Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery
Niosomes improve minoxidil skin delivery for hair loss treatment.
research Transdermal delivery of mixnoxidil with block copolymer nanoparticles
Smaller nanoparticles improve minoxidil delivery through hair follicles.
research A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.
research Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells
Minoxidil boosts growth factor in hair cells, potentially promoting hair growth.